AbCellera Biologics Inc.
ABCL · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 5, 2026 | — | 7.85M | — | -0.17 | — |
| 2026 Q1 | May 11, 2026 | 8.32M | 5.41M | -0.14 | -0.22 | -5.71% |
| 2025 Q4 | February 24, 2026 | 44.90M | 6.67M | -0.03 | -0.18 | -0.93% |
| 2025 Q3 | November 6, 2025 | 8.96M | 6.31M | -0.19 | -0.17 | -13.69% |
| 2025 Q2 | August 7, 2025 | 17.08M | 6.36M | -0.12 | -0.17 | +0.24% |
| 2025 Q1 | May 8, 2025 | 4.24M | 7.31M | -0.15 | -0.17 | +1.00% |
| 2024 Q4 | February 27, 2025 | 5.05M | 7.58M | -0.11 | -0.15 | -11.47% |
| 2024 Q3 | November 4, 2024 | 6.51M | 7.58M | -0.17 | -0.14 | -5.88% |
| 2024 Q2 | August 6, 2024 | 7.32M | 10.15M | -0.13 | -0.15 | -7.72% |
| 2024 Q1 | May 7, 2024 | 9.95M | 11.02M | -0.14 | -0.16 | -4.95% |
| 2023 Q4 | February 20, 2024 | 9.18M | 8.88M | -0.17 | -0.14 | -9.42% |
| 2023 Q3 | November 2, 2023 | 6.60M | 11.90M | -0.10 | -0.14 | +6.09% |
| 2023 Q2 | August 3, 2023 | 10.06M | 12.46M | -0.11 | -0.13 | -13.34% |
| 2023 Q1 | May 4, 2023 | 12.19M | 12.11M | -0.14 | -0.12 | -9.38% |
| 2022 Q4 | February 21, 2023 | 485.42M | 50.80M | -0.10 | 0.01 | -1.12% |
| 2022 Q3 | November 8, 2022 | 101.38M | 74.96M | 0.08 | 0.09 | -3.51% |